Stocks
ANI Pharmaceuticals (ANIP) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 71.9% | 23.4% | 48.1% | 135.6% | 185.2% | 165.5% | |||
| Changes by years, y/y, % | -69pp | -48pp | +25pp | +88pp | +50pp | +5.6% | |||
ANI Pharmaceuticals. R&D/CAPEX, %
ANI Pharmaceuticals. R&D/CAPEX, changes, pp
ANI Pharmaceuticals (ANIP) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 244.3% | 206.5% | 229.4% | 164.0% | 112.2% | 165.5% | ||
| Changes by years, y/y, % | +166pp | +40pp | -22pp | +56pp | -132pp | |||
| Changes by quarters, q/q, % | +136pp | -38pp | +23pp | -65pp | -52pp | |||
